Market News & Trends

1/23/2012

Amgen Invests $200 Million in Monoclonal Antibodies Amgen recently announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore.…

1/16/2013

BIND Biosciences & Amgen Sign Worldwide Development & Commercialization  Agreement BIND Biosciences recently announced it has entered into a global collaboration agreement with Amgen Inc. to…

1/9/2013

Ultragenyx Secures $75 Million for Ultra-Rare Diseases Ultragenyx Pharmaceutical Inc. recently announced the successful completion of a $75-million Series B round financing led by Adage…

12/27/2012

Radius & 3M Announce Exclusive Agreement Radius Health, Inc. and 3M Drug Delivery Systems recently announced an exclusive partnership agreement for development and commercialization of…